Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 1/20 | 0.31 |
| ▸ | METAP1 | P53582 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL497286 | 0.83 | LAP3 (0.39) | LAP3METAP1MMP1MMP2MMP3 | |
| SCHEMBL2185946 | 0.81 | LAP3 (0.37) | LAP3METAP1MMP1MMP2MMP3 | |
| SCHEMBL27714875 | 0.79 | CTSA (0.39) | — | |
| SCHEMBL11410937 | 0.77 | CTSA (0.37) | LAP3METAP1MMP1MMP2MMP3 | |
| SCHEMBL13557334 | 0.77 | MMP1 (0.38) | LAP3METAP1MMP1MMP2MMP3 | |
| SCHEMBL2863833 | 0.75 | BTN3A1 (0.38) | LAP3METAP1 | |
| SCHEMBL11409309 | 0.75 | PPARD (0.39) | LAP3METAP1MMP1MMP2MMP3 | |
| SCHEMBL6014564 | 0.73 | LAP3 (0.41) | LAP3METAP1 | |
| SCHEMBL485995 | 0.73 | — | — | |
| SCHEMBL14777095 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250353949-A1 | ONE-COMPONENT BURN-IN SYSTEM | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-20 | — | — | US | disclosed |
| US-20250297054-A1 | BLOCKED POLYISOCYANATES | COVESTRO DEUTSCHLAND AG (DE) | 2025-09-25 | — | — | US | disclosed |
| US-20250163207-A1 | BLOCKED POLYISOCYANATES | COVESTRO DEUTSCHLAND AG (DE) | 2025-05-22 | — | — | US | disclosed |
| WO-2025087730-A1 | METHOD FOR PREPARING A POLYISOCYANATE BASED ON 1,5-PENTAMETHYLENE DIISOCYANATE | COVESTRO DEUTSCHLAND AG (DE) | 2025-05-01 | — | — | WO | disclosed |
| EP-4545579-A1 | PROCESS FOR THE PREPARATION OF A POLYISOCYANATE BASED ON 1,5-PENTAMETHYLENE DIISOCYANATE | Covestro Deutschland AG (DE) | 2025-04-30 | — | — | EP | disclosed |
| EP-1054029-B1 | Method of improving stability of aromatic polycarbodiimides | ROHM & HAAS (US) | 2005-12-28 | — | — | EP | disclosed |
| US-6797800-B2 | VIA CATALYST SUCH AS TETRABUTYLPHOSPHONIUM-BENZOTRIAZOLEATE IN METHANOL; FOR PRODUCING POLYURETHANE PLASTICS AND COATING POWDERS | BAYER AKTIENGESELLSCHAFT (DE) | 2004-09-28 | — | — | US | disclosed |
| US-20030013872-A1 | Method of dimerizing isophorone diisocyanate | BAYER AKTIENGESELLSCHAFT (DE) | 2003-01-16 | — | — | US | disclosed |
| US-6362247-B1 | DEACTIVATION PHOSPHOLENE CATALYSTS | ROHM AND HAAS COMPANY | 2002-03-26 | — | — | US | disclosed |
| EP-1054029-A1 | Method of improving stability of aromatic polycarbodimides | ROHM AND HAAS COMPANY (US) | 2000-11-22 | — | — | EP | disclosed |
| US-5476892-A | Mixing with a silylated acid; good color and activity properties; producing polyurethane foams | BAYER AKTIENGESELLSCHAFT (DE) | 1995-12-19 | — | — | US | disclosed |
| US-5342881-A | Process for the standardization and stabilization of organic polyisocyanates and the stable products of this process | BAYER AKTIENGESELLSCHAFT (DE) | 1994-08-30 | — | — | US | disclosed |
| US-5260481-A | With silylated acid | BAYER AKTIENGESELLSCHAFT (DE) | 1993-11-09 | — | — | US | disclosed |
| US-5258508-A | Process for the preparation of oligomeric polyisocyanates and their use | BAYER AKTIENGESELLSCHAFT (DE) | 1993-11-02 | — | — | US | disclosed |
| US-5202358-A | Catalytic carbodiimidizing isocyanater groups | BAYER AKTIENGESELLSCHAFT (DE) | 1993-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030013872-A1 | Method of dimerizing isophorone diisocyanate | PUF60, TST, UROD | LAP3 792/4885METAP1 2369/4885MMP1 250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.